Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: GlobalData | PRODUCT CODE: 1159018

Cover Image

PUBLISHER: GlobalData | PRODUCT CODE: 1159018

Mycobacterium Tuberculosis Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

PUBLISHED:
PAGES: 115 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4000
PDF (Site License)
USD 8000
PDF (Global License)
USD 12000

Add to Cart

GlobalData's Medical Devices sector report, "Mycobacterium Tuberculosis Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" provides comprehensive information about the Mycobacterium Tuberculosis Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Traditional diagnosis of Mycobacterial infections depends upon smear positivity in sputum samples, culture and chest radiography. For rapid diagnosis, nucleic acid amplification tests such as polymerase chain reaction (PCR), immune-based assays such as enzyme-linked immunosorbent assay (ELISA), skin patch test and rapid culture systems are performed.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Mycobacterium Tuberculosis Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Mycobacterium Tuberculosis Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Mycobacterium Tuberculosis Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date
Product Code: GDME1451EPD

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Mycobacterium Tuberculosis Tests Overview

3 Products under Development

  • 3.1 Mycobacterium Tuberculosis Tests - Pipeline Products by Stage of Development
  • 3.2 Mycobacterium Tuberculosis Tests - Pipeline Products by Segment
  • 3.3 Mycobacterium Tuberculosis Tests - Pipeline Products by Territory
  • 3.4 Mycobacterium Tuberculosis Tests - Pipeline Products by Regulatory Path
  • 3.5 Mycobacterium Tuberculosis Tests - Pipeline Products by Estimated Approval Date
  • 3.6 Mycobacterium Tuberculosis Tests - Ongoing Clinical Trials

4 Mycobacterium Tuberculosis Tests - Pipeline Products under Development by Companies

  • 4.1 Mycobacterium Tuberculosis Tests Companies - Pipeline Products by Stage of Development
  • 4.2 Mycobacterium Tuberculosis Tests - Pipeline Products by Stage of Development

5 Mycobacterium Tuberculosis Tests Companies and Product Overview

6 Mycobacterium Tuberculosis Tests- Recent Developments

  • 6.1 Sep 06, 2022: AI-based System shows promise in tuberculosis detection
  • 6.2 Apr 26, 2022: AI Dynamics will employ machine learning to triage TB patients more accurately, quickly, simply and inexpensively using cough sound data, bringing affordable early detection to under-resourced and remote locations worldwide
  • 6.3 Feb 17, 2022: Siemens Healthineers and UNICEF partner to help improve access to healthcare in sub-Saharan Africa

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer
Product Code: GDME1451EPD

List of Tables

List of Tables

  • Mycobacterium Tuberculosis Tests - Pipeline Products by Stage of Development
  • Mycobacterium Tuberculosis Tests - Pipeline Products by Segment
  • Mycobacterium Tuberculosis Tests - Pipeline Products by Territory
  • Mycobacterium Tuberculosis Tests - Pipeline Products by Regulatory Path
  • Mycobacterium Tuberculosis Tests - Pipeline Products by Estimated Approval Date
  • Mycobacterium Tuberculosis Tests - Ongoing Clinical Trials
  • Mycobacterium Tuberculosis Tests Companies - Pipeline Products by Stage of Development
  • Mycobacterium Tuberculosis Tests - Pipeline Products by Stage of Development
  • Glossary

List of Figures

List of Figures

  • Mycobacterium Tuberculosis Tests - Pipeline Products by Stage of Development
  • Mycobacterium Tuberculosis Tests - Pipeline Products by Segment
  • Mycobacterium Tuberculosis Tests - Pipeline Products by Territory
  • Mycobacterium Tuberculosis Tests - Pipeline Products by Regulatory Path
  • Mycobacterium Tuberculosis Tests - Pipeline Products by Estimated Approval Date
  • Mycobacterium Tuberculosis Tests - Ongoing Clinical Trials
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!